{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T22:10:12Z","timestamp":1769379012690,"version":"3.49.0"},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1992,11,1]]},"DOI":"10.1093\/clind\/15.supplement_1.s282","type":"journal-article","created":{"date-parts":[[2011,3,17]],"date-time":"2011-03-17T15:11:13Z","timestamp":1300374673000},"page":"S282-S295","source":"Crossref","is-referenced-by-count":13,"title":["Evaluation of New Anti-Infective Drugs for the Treatment and Prevention of Tuberculosis"],"prefix":"10.1093","volume":"15","author":[{"given":"Philip","family":"Hopewell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Cynamon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Starke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Iseman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1992,11]]},"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/15\/Supplement_1\/S282\/20900993\/15-Supplement_1-S282.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T05:43:03Z","timestamp":1507959783000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/15\/Supplement_1\/S282\/273060\/Evaluation-of-New-AntiInfective-Drugs-for-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,11,1]]},"references-count":0,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[1992,11]]},"published-print":{"date-parts":[[1992,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/clind\/15.supplement_1.s282","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[1992,11]]},"published":{"date-parts":[[1992,11,1]]}}}